T HELPER 1/2 LYMPHOCYTE URINARY CYTOKINE PROFILES IN RESPONDING AND NONRESPONDING PATIENTS AFTER 1 AND 2 COURSES OF BACILLUS CALMETTE-GUERIN FOR SUPERFICIAL BLADDER CANCER
- 1 December 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (6) , 2142-2147
- https://doi.org/10.1016/s0022-5347(05)65522-x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- What Is the Optimal Regimen for BCG Intravesical Therapy?European Urology, 2000
- A recombinant BCG vaccine generates a Th1‐like response and inhibits IgE synthesis in BALB/c miceImmunology, 1999
- URINARY INTERLEUKIN-2 MONITORING DURING PROLONGED BACILLUS CALMETTE-GUERIN TREATMENT: CAN IT PREDICT THE OPTIMAL NUMBER OF INSTILLATIONS?Journal of Urology, 1999
- URINARY INTERLEUKIN-8/CREATININE LEVEL AS A PREDICTOR OF RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY IN BLADDER TUMOR PATIENTSJournal of Urology, 1997
- Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder CancerJournal of Urology, 1996
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes.The Journal of Experimental Medicine, 1994
- Immunity to mycobacteriaCurrent Opinion in Immunology, 1993
- Role of Cytokines and CD4+ T‐Cell Subsets in the Regulation of Parasite Immunity and DiseaseImmunological Reviews, 1989
- Experience with intravesical bacillus calmette-guèrin therapy of superficial bladder tumorsUrology, 1985